By Josh White
Date: Tuesday 19 May 2026
(Sharecast News) - Ixico reported higher interim revenue and a larger order book on Tuesday, as new contract wins, extensions and increased biomarker analysis activity supported growth in the first half.
By Josh White
Date: Tuesday 19 May 2026
(Sharecast News) - Avacta Group said on Tuesday that it had strengthened its position as a pure-play oncology biopharmaceutical company during 2025, with progress across its 'preCISION' tumour-activated drug delivery platform and cash runway extended into the first quarter of 2027.
By Benjamin Chiou
Date: Monday 18 May 2026
(Sharecast News) - Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-quarter earnings season.
| Price | 0.00 |
| Closing Price Change | 0.00 |
| % Change | 0.00 % |
| --26 Close | 0.00 |
You are here: research